Evidence map›Paper›PMID 42714220›Full record

ArticleRapid communications in mass spectrometry : RCM2026

Advances in the Design and Functionality of a Compact Multi-Reflecting Time-of-Flight Mass Spectrometer.

Jason Wildgoose, Samantha Ferries, Lee A Gethings, Matthew E Daly, Martin E Palmer, Richard Lock, Johannes P C Vissers, James I Langridge

Abstract read
In one paragraph

Article in Rapid communications in mass spectrometry : RCM, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jason WildgooseWaters Corporation, Wilmslow, UK.ORCID https://orcid.org/0009-0004-4098-6975
Samantha FerriesWaters Corporation, Wilmslow, UK.ORCID https://orcid.org/0009-0002-0176-2907
Lee A GethingsWaters Corporation, Wilmslow, UK.ORCID https://orcid.org/0000-0003-3513-364X
Matthew E DalyWaters Corporation, Wilmslow, UK.ORCID https://orcid.org/0000-0001-7795-8477
Martin E PalmerWaters Corporation, Wilmslow, UK.ORCID https://orcid.org/0000-0003-1658-9334
Richard LockWaters Corporation, Wilmslow, UK.ORCID https://orcid.org/0009-0009-0078-139X
Johannes P C VissersWaters Corporation, Wilmslow, UK.ORCID https://orcid.org/0000-0001-6283-8456
James I LangridgeWaters Corporation, Wilmslow, UK.ORCID https://orcid.org/0000-0003-4104-3501

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

rationaleHigh-resolution mass spectrometry is routinely used for the analysis of complex samples in pharmaceutical, environmental, and omics related studies. Such applications demand instrumentation to be capable of combining sub-ppm mass accuracy, high resolving power, rapid full m/z range acquisition over a wide dynamic range.

methodsAchieving the above requirements places constraints on analyzer design and performance. Multi-reflecting time-of-flight (MRT) based analyzers have previously been reported as a means of significantly extending the effective flight path in compact TOF designs. Here, further instrument and functionality advances in a compact MRT mass spectrometer design are described.

resultsThe impact of these enhancements was assessed for targeted and non-targeted omics applications, examining the impact of acquisition speed on resolving power, dynamic range including limits of quantitation, and quantitative precision.

conclusionThe results obtained characterize the performance of the enhanced design features of a compact MRT mass spectrometer. Operation at elevated acquisition rates up to 200 Hz was observed without loss in resolving power, isotopic ratio accuracy or quantitative precision.

Indexed as

high resolution mass spectrometrymulti‐reflecting time‐of‐flight (MRT)omics

Identifiers

PMID42714220
PMCPMC13556519

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.